The Living With Migraine 2024 syndicated patient report
The Living With Migraine 2024 syndicated patient report offers valuable insights into the Migraine patient experience, from pre-diagnosis to current treatment.
Based on 353 quantitative and qualitative interviews with chronic and episodic Migraine patients in the US, UK, China, Mexico and UAE, this report can provide insights to help inform clinical trial planning, develop patient-focused strategies/communications or enhance patient support programs.
With this report, find out about patients’ perceptions regarding:
- Migraine diagnosis
- Impact of migraine on patients’ lives
- Treatment perceptions and beliefs about treatment, including examining views and experience with acute vs. preventative treatments
- Patient perceptions and beliefs about living with migraine
- Information & support sources accessed by patients
Living With is a series of reports providing a foundational understanding of the patient experience through real-world patient insights. The reports highlight patients’ emotional needs and treatment challenges for a variety of chronic diseases.
If you are interested in the new Living with Migraine 2024 report, please contact us today.
Jump to a slide with the slide dots.
Inizio Ignite Sparks a New Era of Connected Advisory Solutions
Inizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.
Read moreLaunch Readiness Reimagined: Takeaways from Pharma Launch Excellence (PHLEX) summit 2025
PHLEX Summit 2025 reveals how early alignment, agile planning, real-world insights, and AI are reshaping pharma launch excellence.
Read moreInizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series
Inizio Engage CEO Jim Sage shares leadership insights and perspectives on the future of pharma in pharmaphorum’s “12 Questions” interview.
Read more